Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study

Trial Identifier: D822EC00001
Sponsor: AstraZeneca
NCTID:: NCT05665374
Start Date: June 2023
Primary Completion Date: May 2026
Study Completion Date: May 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Japan Aichi, Japan
Japan Chiba, Japan
Japan Fukuoka, Japan
Japan Hyogo, Japan
Japan Ibaraki, Japan
Japan Kanagawa, Japan
Japan Kyoto, Japan
Japan Miyazaki, Japan
Japan Nagano, Japan
Japan Nara, Japan
Japan Oita, Japan
Japan Okayama, Japan
Japan Osaka, Japan
Japan Saitama, Japan
Japan Shizuoka, Japan
Japan Tokyo, Japan
Japan Yamaguchi, Japan
Japan Yamanashi, Japan